山羊抗大鼠IgG H&L (Cy5 ®)预吸附二抗(ab6565)
Key features and details
- Goat Anti-Rat IgG H&L (Cy5 ®) preadsorbed
- Conjugation: Cy5 ®. Ex: 650nm, Em: 667nm
- Host species: Goat
- Isotype: IgG
- Suitable for: ICC, Flow Cyt, ICC/IF, ELISA, IHC-P, IHC-Fr
Related conjugates and formulations
概述
-
产品名称
山羊抗大鼠IgG H&L (Cy5 ®)预吸附二抗
参阅全部 IgG 二抗 -
宿主
Goat -
靶标种属
Rat -
经测试应用
适用于: ICC, Flow Cyt, ICC/IF, ELISA, IHC-P, IHC-Frmore details -
最小交叉反应
Chicken, Cow, Goat, Guinea pig, Hamster, Horse, Human, Mouse, Rabbit, Sheep more details -
免疫原
Rat IgG, whole molecule (H&L)
-
偶联物
Cy5 ®. Ex: 650nm, Em: 667nm
性能
-
形式
Liquid -
存放说明
Shipped at 4°C. Store at +4°C. -
存储溶液
pH: 6.5
Preservative: 0.01% Sodium azide
Constituents: 0.88% Sodium chloride, 1% BSA, 0.424% Tripotassium orthophosphate -
Concentration information loading...
-
纯度
Immunogen affinity purified -
纯化说明
This product was prepared from monospecific antiserum by immunoaffinity chromatography using Rat IgG coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities. -
共轭说明
Cy5.29 (Cyanine 5.29-OSu) (Molecular Weight 975 daltons) Absorption Wavelength: 650 nm Emission Wavelength: 667 nm Fluorochrome/Protein Ratio: 6.0 moles Cy5 per mole of Goat IgG -
克隆
多克隆 -
同种型
IgG -
常规说明
This product or portions thereof is manufactured under license from Carnegie Mellon University under U.S. Patent Number 5,268,486 and related patents. Cy and CyDye are trademarks of GE Healthcare Limited. This material is also subject to proprietary rights of GE Healthcare Bio-Sciences Corp. and Carnegie Mellon University and made and sold under License from GE Healthcare Bio-Sciences Corp. This product is licensed for sale only for research. It is NOT licensed for any other use. There is no implied license hereunder for any commercial use. COMMERCIAL USE shall include: 1 Sale, lease, license or other transfer of the material or any material derived or produced from it. 2 Sale, lease, license or other grant of rights to use this material or any material derived or produced from it. 3 Use of this material to perform services for a fee for third parties. If you require a commercial license to use this material and do not have one, please return this material, unopened to Abcam Plc of 330 Cambridge Science Park, Cambridge, CB4 0FL, and any money paid for the material will be refunded.This secondaryantibody is specifically designed for the detection of multiple primary antibodies (polyclonal or monoclonal) of different host species in experiments where cells are simultaneously labeled without unwanted cross reaction.
-
研究领域
应用
应用 | Ab评论 | 说明 |
---|---|---|
ICC |
Use at an assay dependent concentration.
|
|
Flow Cyt |
Use at an assay dependent dilution.
|
|
ICC/IF |
1/1000 - 1/5000.
|
|
ELISA |
1/10000 - 1/50000.
|
|
IHC-P |
Use at an assay dependent concentration.
|
|
IHC-Fr |
Use at an assay dependent concentration.
|
说明 |
---|
ICC
Use at an assay dependent concentration. |
Flow Cyt
Use at an assay dependent dilution. |
ICC/IF
1/1000 - 1/5000. |
ELISA
1/10000 - 1/50000. |
IHC-P
Use at an assay dependent concentration. |
IHC-Fr
Use at an assay dependent concentration. |
图片
实验方案
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
数据表及文件
-
SDS download
-
Datasheet download
文献 (29)
ab6565 被引用在 29 文献中.
- Fu H & Aladjem MI DNA replication profiling by molecular combing on single DNA fibers. STAR Protoc 3:101290 (2022). PubMed: 35463463
- Moore G et al. DNA fiber combing protocol using in-house reagents and coverslips to analyze replication fork dynamics in mammalian cells. STAR Protoc 3:101371 (2022). PubMed: 35573479
- Jimenez-Sainz J et al. BRCA2 BRC missense variants disrupt RAD51-dependent DNA repair. Elife 11:N/A (2022). PubMed: 36098506
- Takahashi N et al. Replication stress defines distinct molecular subtypes across cancers. Cancer Res Commun 2:503-517 (2022). PubMed: 36381660
- Böhly N et al. Increased replication origin firing links replication stress to whole chromosomal instability in human cancer. Cell Rep 41:111836 (2022). PubMed: 36516748